Literature DB >> 8419804

Phenytoin and dyskinesias: a report of two cases and review of the literature.

M B Harrison1, G R Lyons, E R Landow.   

Abstract

Dyskinesia is a recognized but uncommon side-effect of treatment with phenytoin. Two additional cases of dyskinesia during treatment with phenytoin are described; both had radiographically documented thalamic infarctions. The reported experience to date with movement disorders induced by phenytoin is reviewed and the clinical features summarized. The available experimental evidence addressing the mechanism underlying this side effect is discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8419804     DOI: 10.1002/mds.870080104

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  13 in total

1.  Acceleration of HIV dementia with methamphetamine and cocaine.

Authors:  A Nath; W F Maragos; M J Avison; F A Schmitt; J R Berger
Journal:  J Neurovirol       Date:  2001-02       Impact factor: 2.643

Review 2.  Medication-Induced Tardive Dyskinesia: A Review and Update.

Authors:  Elyse M Cornett; Matthew Novitch; Alan David Kaye; Vijay Kata; Adam M Kaye
Journal:  Ochsner J       Date:  2017

3.  Orofaciolingual dyskinesia due to diphenylhydantoin sodium.

Authors:  Chandrasekharan Rajasekharan; Adlene Manue Tina; Sanu Watson Renjith
Journal:  BMJ Case Rep       Date:  2013-05-23

4.  Movement disorders in patients taking anticonvulsants.

Authors:  C Zadikoff; R P Munhoz; A N Asante; N Politzer; R Wennberg; P Carlen; A Lang
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-09-29       Impact factor: 10.154

5.  Neuroleptic malignant syndrome induced by phenytoin in a patient with drug-induced Parkinsonism.

Authors:  Hae-Won Shin; Young Chul Youn
Journal:  Neurol Sci       Date:  2014-05-29       Impact factor: 3.307

Review 6.  Safety and tolerability of antiepileptic drug treatment in children with epilepsy.

Authors:  Renzo Guerrini; Gaetano Zaccara; Giancarlo la Marca; Anna Rosati
Journal:  Drug Saf       Date:  2012-07-01       Impact factor: 5.606

7.  Generalized myoclonus: a rare manifestation of stroke.

Authors:  Violiza Inoa; Louise D McCullough
Journal:  Neurohospitalist       Date:  2015-01

Review 8.  Drug-induced movement disorders.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz; J A Molina
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

Review 9.  Current Methods for the Treatment and Prevention of Drug-Induced Parkinsonism and Tardive Dyskinesia in the Elderly.

Authors:  Carlos Estevez-Fraga; Paul Zeun; Jose Luis López-Sendón Moreno
Journal:  Drugs Aging       Date:  2018-11       Impact factor: 3.923

Review 10.  Dystonia and chorea in acquired systemic disorders.

Authors:  J L Janavs; M J Aminoff
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-10       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.